PALM BEACH, Fla. – The first day of the National Association of Chain Drug Stores Annual Meeting got off to a fast start at a breakfast on GLP-1s sponsored by retailmediaIQ, publisher of Chain Drug Review and MMR. Building on a webinar devoted to the same topic earlier this year, the session addressed the latest developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors. Moderated by Parag Shah, co-founder, partner and chief growth officer at Think Blue, the panelists included Jim Kirby, chief commercial officer at Kroger Health, Betty Pio, a partner and strategic advisor to pharma and biotech at Kearney, and Sarah Squires, director of Retail Insights Drug Channel at NielsenIQ.
CDR/MMR breakfast at NACDS Annual looks at the latest developments in GLP-1 category
The session addressed the latest GLP-1 developments in a rapidly evolving category that is poised to impact much of what transpires in the food and pharmacy sectors.
Related
Video Forum: Colleen Lindholz, Kroger, and Aaron Wiese, Hy-Vee
The time is right to reimagine retail health.
NACDS Foundation welcomes new members to its board of directors
Directors from Unilever, Kroger Health, Inmar Intelligence, Haleon, Colgate-Palmolive, and Walmart to support the Foundation’s ongoing focus on research and education.
Jim Whitman honored with NACDS’ highest distinction: Sheldon W. Fantle Lifetime Achievement Award
This tribute was particularly significant as Jim has been instrumental in constantly transforming and sustaining the NACDS Annual Meeting and other NACDS meetings and conferences as premier events that foster industry relationships and drive advancement.
Latest
Crave Retail to showcase smart fitting room and store engagement platform at NRF 2026
Crave Retail will showcase its AI-powered smart fitting room and in-store engagement platform powered by Zebra’s retail displays, mobile devices, and RFID solutions.
Ro launches Wegovy pill through deal with Novo Nordisk
Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.
Albertsons Media Collective launches incrementality measurement
Aims to prove true media impact of in-store campaigns and plans expansion.
Camber Pharmaceuticals reviews 2025 achievements and plans 2026 growth
Camber’s year featured broad generic launches, specialty and oncology introductions, emphasizing access, affordability, and supply reliability in the U.S.